Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study of Autologous Bone Marrow Mononuclear Cells in Autism Spectrum Disorders

NCT01974973 is registered in ClinicalTrials.gov with Neurogen Brain and Spine Institute as lead sponsor.

NCT NCT01974973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01974973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study of Autologous Bone Marrow Mononuclear Cells in Autism Spectrum Disorders
Lead sponsor
Neurogen Brain and Spine Institute
Phase
Phase 1
Overall status
Withdrawn
Start date
August 31, 2009
Completion date
May 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders